In patient tumors, treatment with a neutralizing anti-Itgβ8 antibody, as well as single-cell gene-expression analysis on tumor-infiltrating T cells, confirmed the relevance of our findings in mice to human pathology. The gene discussed is ITGB8; the disease is neoplasm.